- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNa guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71:1269–1324.
- Deshmukh A, Kumar G, Kumar N, et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol. 2011;108(9):1277–1282. doi:10.1016/j.amjcard.2011.06.046.
- Janke AT, McNaughton CD, Brody AM, Welch RD, Levy PD. Trends in the incidence of hypertensive emergencies in US emergency departments from 2006 to 2013. J Am Heart Assoc. 2016;5(12):e004511. doi:10.1161/JAHA.116.004511.
- Kumar N, Simek S, Garg N, et al. Thirty-day readmissions after hospitalization for hypertensive emergency. Hypertension. 2019;73(1):60–67. doi:10.1161/HYPERTENSIONAHA.118.11691.
- McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30(1):127–135. doi:10.1681/ASN.2018050531.
- Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 1992;19(5):453–459. doi:10.1016/S0272-6386(12)80954-1.
- Enam N, Kakkad K, Amin A, Lever C. Management of hypertension in the hemodialysis population: a review of the literature. J Community Hosp Intern Med Perspect. 2014;4(3):24055. doi:10.3402/jchimp.v4.24055.
- Healthcare Cost and Utilization Project. HCUP National Inpatient Sample. Last modified September 13, 2021. Accessed February 16, 2022. https://www.hcup-us.ahrq.gov/nisoverview.jsp.
- Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026.
- Samanta R, Chan C, Chauhan VS. Arrhythmias and sudden cardiac death in end stage renal disease: epidemiology, risk factors, and management. Can J Cardiol. 2019;35(9):1228–1240. doi:10.1016/j.cjca.2019.05.005.
- Silva RT, Martinelli Filho M, Peixoto Gde L, et al. Predictors of arrhythmic events detected by implantable loop recorders in renal transplant candidates. Arq Bras Cardiol. 2015;105:493–502.
- Marwick TH, Amann K, Bangalore S, et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(4):836–849. doi:10.1016/j.kint.2019.06.025.
- Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5):853–906. doi:10.1016/s0272-6386(98)70145-3.
- Claus R, Berliner D, Bavendiek U, et al. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD). Clin Res Cardiol. 2020;109(8):1035–1047. doi:10.1007/s00392-020-01597-x.
- Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995;47(3):884–890. doi:10.1038/ki.1995.132.
- Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. 2001;38(5):992–1000. doi:10.1053/ajkd.2001.28588.
- Zoccali C, Torino C, Tripepi R, et al; Lung US in CKD Working Group. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol. 2013;24(4):639–646. doi:10.1681/ASN.2012100990.
- Arneson TJ, Liu J, Qiu Y, Gilbertson DT, Foley RN, Collins AJ. Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol. 2010;5(6):1054–1063. doi:10.2215/CJN.00340110.
- Davis-Ajami ML, Fink JC, Baernholdt M, Wu J. Adverse safety event characteristics and predictive factors in hospital encounters for patients with chronic kidney disease. Am J Nephrol. 2019;50(1):72–80. doi:10.1159/000500562.
- Ning C, Hu X, Liu F, et al. Post-surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10-year results from the US National Inpatient Sample. BMC Nephrol. 2019;20(1):278. doi:10.1186/s12882-019-1455-2.
- Fenves AZ, Ram CVS. Drug treatment of hypertensive urgencies and emergencies. Semin Nephrol. 2005;25(4):272–280. doi:10.1016/j.semnephrol.2005.02.011.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
Original Research
Impact of end-stage renal disease on in-hospital outcomes of hypertensive emergency from the National Inpatient Sample, 2016 to 2018
Dae Yong Parka Department of Medicine, Cook County Health, Chicago, IllinoisCorrespondence[email protected]
https://orcid.org/0000-0002-1486-7452
, MDhttps://orcid.org/0000-0002-1486-7452, Seokyung Anb Department of Biomedical Science, Seoul National University Graduate School, Seoul, Koreahttps://orcid.org/0000-0002-1971-1094
, BShttps://orcid.org/0000-0002-1971-1094, , MD, , MD, , MD, , MD & , MD show all